Shares of Corbus Pharmaceuticals (NASDAQ:CRBP) decreased 1.5% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 71.15% year over year to ($0.15), which missed the estimate of ($0.12).
Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.15) per share. This is a 71.15 percent increase over losses of $(0.52) per share from the same period last year. The company reported $137.00